Towards control of magnetic fluids in patients: Directing therapeutic nanoparticles to disease locations

IEEE Control Systems

Volumn 32, Issue 3, 2012, Pages 32-74

  Nacev, Aleksander ^a   Komaee, Arash ^a   Sarwar, Azeem ^b   Probst, Roland ^b   Kim, Skye H ^c   Emmert Buck, Michael ^d,e   Shapiro, Benjamin ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^d NCI   (United States)

^e U S PUBLIC HEALTH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENTS; DIMENSIONAL PARAMETERS; MAGNET DESIGNS; MAGNETIC ENERGIES; OPTIMAL CONTROLS; OPTIMAL FEEDBACK CONTROL; PARAMETER SPACES; QUADRATIC DEPENDENCE;

DISEASE CONTROL; DRUG DELIVERY; EQUIPMENT TESTING; MAGNETS; NANOPARTICLES; OPTIMIZATION;

NANOMAGNETICS;

EID: 84871832551     PISSN: 1066033X     EISSN: None     Source Type: Journal    
DOI: 10.1109/MCS.2012.2189052     Document Type: Review

References (306)

1. R. Reszka, P. Beck, I. Fichtner, M. Hentschel, J. Richter, and J. Kreuter, "Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice," J. Pharmacol. Experiment. Therapeut., vol. 280, pp. 232-237, Jan. 1997. (Pubitemid 27171407)
2. M. C. Perry, The Chemotherapy Source Book. Philadelphia, PA: Wolters Kluwer Health, 2008.
3. S. B. Horwitz, "Taxol (paclitaxel): Mechanisms of action," Ann. Oncol.: Official J. Eur. Soc. Medical Oncol./ESMO, vol. 5, suppl. 6, pp. S3-S6, 1994.
4. D. Lorusso, A. Pietragalla, S. Mainenti, V. Masciullo, G. Di Vagno, and G. Scambia, "Review role of topotecan in gynaecological cancers: Current indications and perspectives," Crit. Rev. Oncol./Hematol., vol. 74, pp. 163-174, June 2010.
5. S. B. Duffull and B. A. Robinson, "Clinical pharmacokinetics and dose optimisation of carboplatin," Clin. Pharmacokinet., vol. 33, pp. 161-183, Sept. 1997.
6. S. Rockwell and G. B. Grindey, "Effect of 2′,2′- difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro," Oncol. Res., vol. 4, no. 4-5, pp. 151-155, 1992. (Pubitemid 23167108)
7. E. Mini, S. Nobili, B. Caciagli, I. Landini, and T. Mazzei, "Cellular pharmacology of gemcitabine," Ann. Oncol.: Official J. Eur. Soc. Med. Oncol./ESMO, vol. 17, suppl. 5, pp. v7-v12, May 2006.
8. T. De Vita, Jr., S. Hellman, and S. A. Rosenberg, Cancer, Principles and Practice of Oncology, 8th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2008.
9. B. Chabner and D. Longo, Cancer Chemotherapy and Biotherapy: Principles and Practice, 5th ed. Philadelphia, PA: Wolters Kluwer Health, 2011.
10. N. M. Orekhova, R. S. Akchurin, A. A. Belyaev, M. D. Smirnov, S. E. Ragimov, and A. N. Orekhov, "Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells," Thromb. Res., vol. 57, no. 4, p. 611-616, 1990.
11. A. S. Lubbe, C. Bergemann, H. Riess, F. Schriever, P. Reichardt, K. Possinger, M. Matthias, B. Dorken, F. Herrmann, R. Gurtler, P. Hohenberger, N. Haas, R. Sohr, B. Sander, A. J. Lemke, D. Ohlendorf, W. Huhnt, and D. Huhn, "Clinical experiences with magnetic drug targeting: A phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors," Cancer Res., vol. 56, no. 20, pp. 4686-4693, 1996. (Pubitemid 26338071)
12. V. P. Torchilin, "Drug targeting," Eur. J. Pharmaceut. Sci., vol. 11, no. 4, pp. 81-91, 2000.
13. A. S. Lubbe, C. Alexiou, and C. Bergemann, "Clinical applications of magnetic drug targeting," J. Surg. Res., vol. 95, no. 2, pp. 200-206, 2001. (Pubitemid 34953556)
14. M. Shinkai, "Functional magnetic particles for medical application," J. Biosci. Bioeng., vol. 94, no. 6, pp. 606-613, 2002. (Pubitemid 36132562)
15. C. Alexiou, R. Jurgons, R. J. Schmid, C. Bergemann, J. Henke, W. Erhardt, E. Huenges, and F. Parak, "Magnetic drug targeting - Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment," J. Drug Target., vol. 11, no. 3, pp. 139-149, 2003. (Pubitemid 37236327)
16. D. L. Holligan, G. T. Gillies, and J. P. Dailey, "Magnetic guidance of ferrofluidic nanoparticles in an in vitro model of intraocular retinal repair," Nanotechnology, vol. 14, no. 6, pp. 661-666, 2003.
17. Q. A. Pankhurst, J. Connolly, S. K. Jones, and J. Dobson, "Applications of magnetic nanoparticles in biomedicine," J. Phys. D: Appl. Phys., vol. 36, no. 13, pp. R167-R181, 2003.
18. R. Jurgons, C. Seliger, A. Hilpert, L. Trahms, S. Odenbach, and C. Alexiou, "Drug loaded magnetic nanoparticles for cancer therapy," J. Phys.-Condens. Matter, vol. 18, no. 38, pp. S2893-S2902, 2006. (Pubitemid 44523008)
19. C. Alexiou, R. Jurgons, C. Seliger, B. Schick, S. Kolb, and H. Iro, "Magnetic drug targeting in cancers of the head and neck," Laryngo-Rhino-Otologie, vol. 85, no. 11, pp. 857-859, 2006. (Pubitemid 44831579)
20. J. Dobson, "Magnetic micro- and nano-particle-based targeting for drug and gene delivery," Nanomedicine, vol. 1, no. 1, pp. 31-37, 2006.
21. M. Arruebo, R. Fernandez-Pacheco, M. R. Ibarra, and J. Santamaria, "Magnetic nanoparticles for drug delivery," Nano Today, vol. 2, no. 3, pp. 22-32, 2007.
22. M. Johannsen, U. Gneveckow, B. Thiesen, K. Taymoorian, C. H. Cho, N. Waldofner, R. Scholz, A. Jordan, S. A. Loening, and P. Wust, "Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution," Eur. Urol., vol. 52, pp. 1653-1661, Dec. 2007.
23. C. Sun, J. Lee, and M. Zhang, "Magnetic nanoparticles in MR imaging and drug delivery," Adv. Drug Deliv. Rev., vol. 60, pp. 1252-1265, Aug. 2008.
24. Q. A. Pankhurst, N. K. Thanh, S. K. Jones, and J. Dobson, "Progress in applications of magnetic nanoparticles in biomedicine," J. Phys. D: Appl. Phys., vol. 42, no. 22, pp. 224,001-224,016, 2009.
25. N. Tran and T. J. Webster, "Magnetic nanoparticles: Biomedical applications and challenges," J. Mater. Chem., vol. 20, no. 40, pp. 8760-8767, 2010.
26. J. Dobson, "Magnetic nanoparticles for drug delivery," Drug Develop. Res., vol. 67, no. 1, pp. 55-60, 2006.
27. K. Maier-Hauff, R. Rothe, R. Scholz, U. Gneveckow, P. Wust, B. Thiesen, A. Feussner, A. von Deimling, N. Waldoefner, R. Felix, and A. Jordan, "Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme," J. Neuro-Oncol., vol. 81, pp. 53-60, Jan. 2007. (Pubitemid 44963989)
28. P. K. Stoimenov, R. L. Klinger, G. L. Marchin, and K. J. Klabunde, "Metal oxide nanoparticles as bactericidal agents," Langmuir, vol. 18, pp. 6679-6686, Aug. 2002.
29. P. Gong, H. Li, X. He, K. Wang, J. Hu, W. Tan, S. Zhang, and X. Yang, "Preparation and antibacterial activity of Fe3O4@Ag nanoparticles," Nanotechnology, vol. 18, pp. 285604-285611, July 2007.
30. E. D. Allen and J. H. Burdette, Questions and Answers in MRI. 2nd ed., St. Louis, MO: Mosby, 2001.
31. A. J. Lemke, M. I. S. von Pilsach, A. Lubbe, C. Bergemann, H. Riess, and R. Felix, "MRI after magnetic drug targeting in patients with advanced solid malignant tumors," Eur. Radiol., vol. 14, no. 11, pp. 1949-1955, 2004. (Pubitemid 39481162)
32. S. Fricke, I. N. Weinberg, P. Stepanov, S. Glidden, A. McMillan, and P. M. Starewicz, "Threshold for peripheral nerve stimulation with ultra-fast gradients," in Proc. 19th Meeting Society for Magnetic Resonance in Medicine, Montreal, Canada, 2011, p. 1787.
33. N. K. Devaraj, E. J. Keliher, G. M. Thurber, M. Nahrendorf, and R. Weissleder, "18F labeled nanoparticles for in vivo PET-CT imaging," Bioconjug. Chem., vol. 20, no. 2, pp. 397-401, 2009.
34. S. I. Parker, C. J. Kenney, D. Gnani, A. C. Thompson, E. Mandelli, G. Meddeler, J. Hasi, J. Morse, and E. M. Westbrook, "3DX: An X-ray pixel array detector with active edges," IEEE Trans. Nuclear Sci., vol. 53, no. 3, pp. 1676-1688, 2006. (Pubitemid 44109480)
35. C. J. Kenney, J. D. Segal, E. M. Westbrook, S. Paker, J. Hasi, C. DaVia, S. Watts, and J. Morse, "Active-edge planar radiation sensors," Nuclear Instrum. Methods Phys. Res. A, vol. 565, no. 1, pp. 272-277, 2006.
36. B. Gleich and J. Weizenecker, "Tomographic imaging using the nonlinear response of magnetic particles," Nature, vol. 435, pp. 1214-1217, June 2005. (Pubitemid 40943083)
37. M. Mahmoudi, V. Serpooshan, and S. Laurent, "Engineered nanoparticles for biomolecular imaging," Nanoscale, vol. 3, no. 8, pp. 3007-3026, 2011.
38. Y. Ishihara, T. Kuwabara, and N. Wadamori, "Sensitivity improvement of a molecular imaging technique based on magnetic nanoparticles," in Medical Imaging 2011: Biomedical Applications in Molecular, Structural, and Functional Imaging (SPIE, vol. 7965), J. B. Weaver and R. C. Molthen, Eds. 2011 p. 79652J.
39. T. Knopp, S. Biederer, T. F. Sattel, J. Rahmer, J. Weizenecker, B. Gleich, J. Borgert, and T. M. Buzug, "2D model-based reconstruction for magnetic particle imaging," Med. Phys., vol. 37, no. 2, pp. 485-492, 2010.
40. T. Knopp, T. F. Sattel, S. Biederer, J. Rahmer, J. Weizenecker, B. Gleich, J. Borgert, and T. M. Buzug, "Model-based reconstruction for magnetic particle imaging," IEEE Trans. Med. Imag., vol. 29, no. 1, pp. 12-18, 2010.
41. S. Biederer, T. Knopp, T. F. Sattel, K. Ludtke-Buzug, B. Gleich, J. Weizenecker, J. Borgert, and T. M. Buzug, "Magnetization response spectroscopy of superparamagnetic nanoparticles for magnetic particle imaging," J. Phys. D: Appl. Phys., vol. 42, pp. 42-49, 2009.
42. T. J. Dougherty, C. J. Gomer, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng, "Photodynamic therapy," J. Nat. Cancer Inst, vol. 90, no. 12, pp. 889-905, 1998.
43. B. W. Barry, "Novel mechanisms and devices to enable successful transdermal drug delivery," Eur. J. Pharmaceut. Sci., vol. 14, no. 2, pp. 101-114, 2001.
44. A. R. Denet, R. Vanbever, and V. Preat, "Skin electroporation for transdermal and topical delivery," Adv. Drug Deliv. Rev., vol. 56, no. 5, pp. 659-674, 2004. (Pubitemid 38326938)
45. W. G. Pitt, G. A. Husseini, and B. J. Staples, "Ultrasonic drug delivery - A general review," Expert Opin. Drug Deliv., vol. 1, no. 1, pp. 37-56, 2004.
46. Z. G. Gao, H. D. Fain, and N. Rapoport, "Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound," J. Control. Release, vol. 102, no. 1, pp. 203-222, 2005. (Pubitemid 40093786)
47. J. F. Schenck, "Safety of strong, static magnetic fields," J. Magn. Reson. Imag., vol. 12, pp. 2-19, July 2000.
48. D. J. Schaefer, J. D. Bourland, and J. A. Nyenhuis, "Review of patient safety in time-varying gradient fields," J. Magn. Reson. Imag., vol. 12, pp. 20-29, July 2000.
49. E. Andersen, "Magnetic resonance imaging-Safety and health issues," AAOHN J., vol. 55, pp. 137-139, Apr. 2007.
50. S. Martel, O. Felfoul, J. B. Mathieu, A. Chanu, S. Tamaz, M. Mohammadi, M. Mankiewicz, and N. Tabatabaei, "MRI-based medical nanorobotic platform for the control of magnetic nanoparticles and flagellated bacteria for target interventions in human capillaries," Int. J. Robot. Res., vol. 28, no. 9, pp. 1169-1182, 2009.
51. C. Catana, Y. Wu, M. S. Judenhofer, J. Qi, B. J. Pichler, and S. R. Cherry, "Simultaneous acquisition of multislice PET and MR images: Initial results with a MR-compatible PET scanner," J. Nuclear Med., vol. 47, no. 12, pp. 1968-76, 2006. (Pubitemid 47544984)
52. W. T. Katsiyiannis, D. P. Melby, J. L. Matelski, V. L. Ervin, K. L. Laverence, and C. C. Gornick, "Feasibility and safety of remote-controlled magnetic navigation for ablation of atrial fibrillation," Amer. J. Cardiol., vol. 102, no. 12, pp. 1674-1676, 2008.
53. A. Haake and J. Dual, "Contactless micromanipulation of small particles by an ultrasound field excited by a vibrating body," J. Acoust. Soc. Amer., vol. 117, pp. 2752-2760, May 2005. (Pubitemid 40675143)
54. S. Oberti, D. Moller, A. Neild, J. Dual, F. Beyeler, B. Nelson, and S. Gutmann, "Strategies for single particle manipulation using acoustic and flow fields," Ultrasonics, vol. 50, pp. 247-257, Feb. 2010.
55. C. Polk and E. Postow, Handbook of Biological Effects of Electromagnetic Fields. Boca Raton, FL: CRC Press, 1996.
56. J. Villemejane and L. M. Mir, "Review. Physical methods of nucleic acid transfer: General concepts and applications," Brit. J. Pharmacol., vol. 157, no. 2, pp. 207-219, 2009.
57. R. G. Hawley, F. H. Lieu, A. Z. Fong, and T. S. Hawley, "Versatile retroviral vectors for potential use in gene therapy," Gene Ther., vol. 1, no. 2, pp. 136-138, 1994.
58. S. Li and L. Huang, "Nonviral gene therapy: Promises and challenges," Gene Ther., vol. 7, no. 1, pp. 31-34, 2000. (Pubitemid 30077146)
59. S. W. Kamau, "Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field," Nucleic Acids Res., vol. 34, pp. e40-e40, Mar. 2006.
60. S. C. McBain, U. Griesenbach, S. Xenariou, A. Keramane, C. D. Batich, E. W. F. W. Alton, and J. Dobson, "Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays," Nanotechnology, vol. 19, pp. 405102-405107, Oct. 2008.
61. E. Stride, C. Porter, A. G. Prieto, and Q. Pankhurst, "Enhancement of microbubble mediated gene delivery by simultaneous exposure to ultrasonic and magnetic fields," Ultrasound Med. Biol., vol. 35, pp. 861-868, May 2009.
62. C. C. Berry, "Progress in functionalization of magnetic nanoparticles for applications in biomedicine," J Phys D: Appl. Phys., vol. 42, no. 22, pp. 224003-224012, 2009.
63. A. G. Roca, R. Costo, A. F. Rebolledo, S. Veintemillas-Verdaguer, P. Tartaj, T. Gonzalez-Carreno, M. P. Morales, and C. J. Serna, "Progress in the preparation of magnetic nanoparticles for applications in biomedicine," J. Phys. D: Appl. Phys., vol. 42, pp. 224002-224012, Nov. 2009.
64. O. Veiseh, J. W. Gunn, and M. Zhang, "Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging," Adv. Drug Deliv. Rev., vol. 62, pp. 284-304, Mar. 2010.
65. D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos, "Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors," Pharmacol. Rev., vol. 51, pp. 691-743, Dec. 1999.
66. K. Cho, X. Wang, S. Nie, Z. Chen, and D. M. Shin, "Therapeutic nanoparticles for drug delivery in cancer," Clin. Cancer Res., vol. 14, pp. 1310-1316, Mar. 2008. (Pubitemid 351413909)
67. U. Zimmermann and G. Pilwat, "Organ specific application of drugs by means of cellular capsule systems," Zeitschrift Naturforschung C Biosciences, vol. 31, no. 11-12, pp. 732-736, 1976.
68. A. Solanki, J. D. Kim, and K. Lee, "Nanotechnology for regenerative medicine: Nanomaterials for stem cell imaging," Nanomedicine, vol. 3, pp. 567-578, Aug. 2008.
69. R. Weissleder, A. Bogdanov, E. A. Neuwelt, and M. Papisov, "Long-circulating iron oxides for MR imaging," Adv. Drug Deliv. Rev., vol. 16, pp. 321-334, Sept. 1995.
70. S. Yu and G. M. Chow, "Preparation of polymer-coated functionalized ferrimagnetic iron oxide nanoparticles," Massachusetts Institute of Technology, Cambridge, MA, 2004.
71. A. J. Cole, A. E. David, J. Wang, C. J. Galban, H. L. Hill, and V. C. Yang, "Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting," Biomaterials, vol. 32, no. 8, pp. 2183-2193, 2010.
72. A. Figuerola, R. Di Corato, L. Manna, and T. Pellegrino, "From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications," Pharmacol. Res., vol. 62, no. 2, pp. 126-143, 2010.
73. M. W. Wilson, R. K. Kerlan, N. A. Fidelman, A. P. Venook, J. M. LaBerge, J. Koda, and R. L. Gordon, "Hepatocellular carcinoma: Regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite-initial experience with four patients," Radiology, vol. 230, no. 1, pp. 287-293, 2004. (Pubitemid 37549815)
74. M. Johannsen, U. Gneveckow, L. Eckelt, A. Feussner, N. Waldofner, R. Scholz, S. Deger, P. Wust, S. A. Loening, and A. Jordan, "Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique," Int. J. Hypertherm., vol. 21, pp. 637-647, Nov. 2005. (Pubitemid 41684238)
75. T. Sato and R. Ruch, Stabilization of Colloidal Dispersions by Polymer Adsorption, vol. 9. New York: Dekker, 1980.
76. J. Park, G. von Maltzahn, L. Zhang, M. P. Schwartz, E. Ruoslahti, S. N. Bhatia, and M. J. Sailor, "Magnetic iron oxide nanoworms for tumor targeting and imaging," Adv. Mater., vol. 20, pp. 1630-1635, May 2008.
77. V. P. Torchilin, "Recent advances with liposomes as pharmaceutical carriers," Nat. Rev. Drug Discov., vol. 4, pp. 145-160, Feb. 2005.
78. N. Nasongkla, E. Bey, J. Ren, H. Ai, C. Khemtong, J. S. Guthi, S. F. Chin, A. D. Sherry, D. A. Boothman, and J. Gao, "Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems," Nano Lett., vol. 6, no. 11, pp. 2427-2430, 2006. (Pubitemid 46076928)
79. S. Lecommandoux, O. Sandre, F. Checot, and R. Perzynski, "Smart hybrid magnetic self-assembled micelles and hollow capsules," Progr. Solid-State Chem., vol. 34, pp. 171-179, July 2006. (Pubitemid 44183596)
80. P. G. Kyrtatos, P. Lehtolainen, M. Junemann-Ramirez, A. Garcia-Prieto, A. N. Price, J. F. Martin, D. G. Gadian, Q. A. Pankhurst, and M. F. Lythgoe, "Magnetic tagging increases delivery of circulating progenitors in vascular injury," JACC Interv., vol. 2, no. 8, pp. 794-802, 2009.
81. Z. Y. Huang, N. Pei, Y. Y. Wang, X. X. Xie, A. J. Sun, L. Shen, S. N. Zhang, X. B. Liu, Y. Z. Zou, J. Y. Qian, and J. B. Ge, "Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics," Biomaterials, vol. 31, no. 8, pp. 2130-2140, 2010.
82. B. Bonnemain, "Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review," J. Drug Target., vol. 6, no. 3, pp. 167-174, 1998. (Pubitemid 29034284)
83. M. G. Harisinghani, J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, and R. Weissleder, "Noninvasive detection of clinically occult lymph-node metastases in prostate cancer," New Engl. J. Med., vol. 348, pp. 2491-2499, June 2003. (Pubitemid 36706536)
84. A. Singh, T. Patel, J. Hertel, M. Bernardo, A. Kausz, and L. Brenner, "Safety of ferumoxytol in patients with anemia and CKD," Amer. J. Kidney Diseases: Official J. Nat. Kidney Foundat., vol. 52, pp. 907-915, Nov. 2008.
85. Y. X. Wang, S. M. Hussain, and G. P. Krestin, "Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging," Eur. Radiol., vol. 11, no. 11, pp. 2319-2331, 2001.
86. A. S. Lubbe, C. Bergemann, W. Huhnt, T. Fricke, H. Riess, J. W. Brock, and D. Huhn, "Preclinical experiences with magnetic drug targeting: Tolerance and efficacy," Cancer Res., vol. 56, no. 20, pp. 4694-4701, 1996. (Pubitemid 26338072)
87. A. Lemke, B. Sander, A. Luebbe, H. Riess, N. Hosten, and R. Felix, "MR imaging after magnetic drug targeting in patients with soft-tissue tumors," Radiology, vol. 201, pp. 1421-1421, 1996.
88. A. Nacev, C. Beni, O. Bruno, and B. Shapiro, "The behaviors of ferromagnetic nano-particles in and around blood vessels under applied magnetic fields," J. Magn. Magn. Mater., vol. 323, no. 6, pp. 651-668, 2011.
89. A. D. Grief and G. Richardson, "Mathematical modeling of magnetically targeted drug delivery," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 455-463, 2005. (Pubitemid 40608966)
90. A. Nacev, C. Beni, O. Bruno, and B. Shapiro, "Magnetic nanoparticle transport within flowing blood and into surrounding tissue," Nanomedicine, vol. 5, no. 9, pp. 1459-1466, 2010.
91. A. Nacev, S. H. Kim, J. Rodiguez-Canales, M. A. Tangrea, B. Shapiro, and M. R. Emmert-Buck, "A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: A feasibility study using simulations on autopsy specimens," Int. J. Nanomed., vol. 6, no. 1, pp. 2907-2923, 2011.
92. A. E. David, A. J. Cole, B. Chertok, Y. S. Park, and V. C. Yang, "A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo," J. Control. Release, vol. 152, no. 1, pp. 67-75, 2011.
93. S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain, "Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment," Proc. Nat. Acad. Sci., vol. 95, no. 8, pp. 4607-4612, 1998. (Pubitemid 28207960)
94. D. B. Montgomery, Solenoid Magnet Design. New York: Wiley, 1969.
95. H. Xu, S. M. Conolly, G. C. Scott, and A. Macovski, "Homogeneous magnet design using linear programming," IEEE Trans. Magn., vol. 36, no. 2, pp. 476-483, 2000. (Pubitemid 30581572)
96. K. Preis, O. Biro, M. Friedrich, A. Gottvald, and C. Magele, "Comparison of different optimization strategies in the design of electromagnetic devices," IEEE Trans. Magn., vol. 27, no. 5, pp. 4154-4157, 1991.
97. S. Martel, C. C. Tremblay, S. Ngakeng, and G. Langlois, "Controlled manipulation and actuation of micro-objects with magnetotactic bacteria," Appl. Phys. Lett., vol. 89, no. 23, pp. 233904-233904-3, 2006.
98. S. Martel, J. Mathieu, O. Felfoul, A. Chanu, E. Aboussouan, S. Tamaz, P. Pouponneau, L. Yahia, G. Beaudoin, G. Soulez, and M. Mankiewicz, "Medical and technical protocol for automatic navigation of a wireless device in the carotid artery of a living swine using a standard clinical MRI system," Med. Image Comput. Comput.-Assist. Interv., 2007, pp. 144-152.
99. S. Martel, M. Mohammadi, O. Felfoul, Z. Lu, and P. Pouponneau, "Flagellated magnetotactic bacteria as controlled MRI-trackable propulsion and steering systems for medical nanorobots operating in the human microvasculature," Int. J. Robot. Res., vol. 28, no. 4, pp. 571-582, 2009.
100. A. Komaee and B. Shapiro, "Steering a ferromagnetic particle by optimal magnetic feedback control," IEEE Trans. Contr. Syst. Technol., June 2011, pp. 6543-6548.
101. B. Shapiro, R. Probst, H. E. Potts, D. A. Diver, and A. Lubbe, "Control to concentrate drug-coated magnetic particles to deep-tissue tumors for targeted cancer chemotherapy," in Proc. 46th IEEE Conf. Decision and Control, New Orleans, LA, 2007, pp. 3901-3906.
102. B. Shapiro, "Towards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the body," J. Magn. Magn. Mater., vol. 321, no. 10, pp. 1594-1599, 2009.
103. U. O. Hafeli, M. A. Lobedann, J. Steingroewer, L. R. Moore, and J. Riffle, "Optical method for measurement of magnetophoretic mobility of individual magnetic microspheres in defined magnetic field," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 224-239, 2005. (Pubitemid 40608934)
104. E. B. Denkba, E. Kilicay, C. Birlikseven, and E. Ozturk, "Magnetic chitosan microspheres: Preparation and characterization," React. Funct. Polymers, vol. 50, no. 3, pp. 225-232, 2002. (Pubitemid 34154057)
105. K. J. Widder, R. M. Morris, G. Poore, D. P. Howard, and A. E. Senyei, "Tumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin," Proc. Nat. Acad. Sci., vol. 78, no. 1, pp. 579-581, 1981. (Pubitemid 11140731)
106. A. Senyei, K. Widder, and G. Czerlinski, "Magnetic guidance of drug carrying microspheres," J. Appl. Phys., vol. 49, no. 6, pp. 3578-3583, 1978. (Pubitemid 8620423)
107. H. Xu, T. Song, X. Bao, and L. Hu, "Site-directed research of magnetic nanoparticles in magnetic drug targeting," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 514-519, 2005. (Pubitemid 40608973)
108. R. E. Rosensweig, Ferrohydrodynamics. Mineola, NY: Dover, 1985.
109. Y. Okuhata, "Delivery of diagnostic agents for magnetic resonance imaging," Adv. Drug Deliv. Rev., vol. 37, no. 1-3, pp. 121-137, 1999. (Pubitemid 29164504)
110. R. L. Fournier, Basic Transport Phenomena in Biomedical Engineering. New York: Taylor & Francis, 2007.
111. W. M. Saltzman, Drug Delivery: Engineering Principles for Drug Therapy. New York: Oxford Univ. Press, 2001.
112. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D. A. Berk, V. P. Torchilin, and R. K. Jain, "Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size," Cancer Res., vol. 55, no. 17, pp. 3752-3756, 1995.
113. C. Zhang, M. Jugold, E. C. Woenne, T. Lammers, B. Morgenstern, M. M. Mueller, H. Zentgraf, M. Bock, M. Eisenhut, and W. Semmler, "Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner," Cancer Res., vol. 67, no. 4, pp. 1555-1562, 2007. (Pubitemid 46383379)
114. A. Natarajan, C. Gruettner, R. Ivkov, G. L. DeNardo, G. Mirick, A. Yuan, A. Foreman, and S. J. DeNardo, "NanoFerrite particle based radioimmunonanoparticles: Binding affinity and in vivo pharmacokinetics," Bioconjug. Chem, vol. 19, no. 6, pp. 1211-1218, 2008. (Pubitemid 351874943)
115. L. Josephson, M. F. Kircher, U. Mahmood, Y. Tang, and R. Weissleder, "Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes," Bioconjug. Chem., vol. 13, no. 3, pp. 554-560, 2002. (Pubitemid 34527517)
116. C. Alexiou, D. Diehl, P. Henninger, H. Iro, R. Rockelein, W. Schmidt, and H. Weber, "A high field gradient magnet for magnetic drug targeting," IEEE Trans. Appl. Superconduct., vol. 16, no. 2, pp. 1527-1530, 2006. (Pubitemid 44150135)
117. J. Ally, B. Martin, M. B. Khamesee, W. Roa, and A. Amirfazli, "Magnetic targeting of aerosol particles for cancer therapy," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 442-449, 2005. (Pubitemid 40608964)
118. P. Dames, B. Gleich, A. Flemmer, K. Hajek, N. Seidl, F. Wiekhorst, D. Eberbeck, I. Bittmann, C. Bergemann, T. Weyh, L. Trahms, J. Rosenecker, and C. Rudolph, "Targeted delivery of magnetic aerosol droplets to the lung," Nat. Nano, vol. 2, no. 8, pp. 495-499, 2007. (Pubitemid 47220067)
119. K. Magnetics. (2011). K&J magnetics-Neodymium magnet specifications. [Online]. Available: http://www.kjmagnetics.com/specs.asp
120. M. Sagawa, S. Fujimura, N. Togawa, H. Yamamoto, and Y. Matsuura, "New material for permanent magnets on a base of Nd and Fe," J. Appl. Phys., vol. 55, no. 6, pp. 2083-2087, 1984.
121. S. Goodwin, C. Peterson, C. Hoh, and C. Bittner, "Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy," J. Magn. Magn. Mater., vol. 194, no. 1-3, pp. 132-139, 1999.
122. M. Lohakan, P. Junchaichanakun, S. Boonsang, and C. Pintavirooj, "A computational model of magnetic drug targeting in blood vessel using finite element method," in Proc. 2nd IEEE Conf. Industrial Electronics and Applications, 2007, pp. 231-234.
123. Y. Yang, J. Jiang, B. Du, Z. Gan, M. Qian, and P. Zhang, "Preparation and properties of a novel drug delivery system with both magnetic and biomolecular targeting," J. Mater. Sci.: Mater. Med., vol. 20, no. 1, pp. 301-307, 2009.
124. I. Slabu, A. Roth, T. Schmitz-Rode, and M. Baumann, "Optimization of magnetic drug targeting by mathematical modeling and simulation of magnetic fields," in Proc. 4th European Conf. Int. Federation for Medical and Biological Engineering, 2009, pp. 2309-2312.
125. A. Sarwar, A. Nemirovski, and B. Shapiro, "Optimal halbach permanent magnet designs for maximally pulling and pushing nanoparticles," J. Magn. Magn. Mater, vol. 324, no. 5, pp. 742-754.
126. D. C. Meeker, E. H. Maslen, R. C. Ritter, and F. M. Creighton, "Optimal realization of arbitrary forces in a magnetic stereotaxis system," IEEE Trans. Magn., vol. 32, no. 2, pp. 320-328, 1996.
127. M. S. Grady, M. A. Howard, III, R. G. Dacey, Jr, W. Blume, M. Lawson, P. Werp, and R. C. Ritter, "Experimental study of the magnetic stereotaxis system for catheter manipulation within the brain," J. Neurosurg., vol. 93, no. 2, pp. 282-288, 2000. (Pubitemid 30604871)
128. F. M. Creighton, "Control of magnetomotive actuators for an implanted object in brain and phantom materials," Ph.D. dissertation, Univ. Virginia, 1991.
129. M. S. Grady, M. A. Howard, III, J. A. Molloy, R. C. Ritter, E. G. Quate, and G. T. Gillies, "Nonlinear magnetic stereotaxis: Three-dimensional, in vivo remote magnetic manipulation of a small object in canine brain," Med. Phys., vol. 17, no. 3, pp. 405-415, 1990.
130. M. A. Howard, III, R. C. Ritter, and M. S. Grady, "Video tumor fighting system," U.S. Patent 4869247, 1989.
131. R. C. Ritter, "Open field system for magnetic surgery," U.S. Patent 6241671, 2001.
132. P. R. Werp, "Methods and apparatus for magnetically controlling motion direction of a mechanically pushed catheter," U.S. Patent 6015414, 2002.
133. F. J. Bova and W. A. Friedman, "Computer controlled guidance of a biopsy needle," U.S. Patent 6546279, 2003.
134. Y. M. Eyssa, "Apparatus and methods for controlling movement of an object through a medium using a magnetic field," U.S. Patent 6842324, 2005.
135. T. Bauernfeind, F. Akca, B. Schwagten, N. de Groot, Y. Van Belle, S. Valk, B. Ujvari, L. Jordaens, and T. Szili-Torok, "The magnetic navigation system allows safety and high efficacy for ablation of arrhythmias," Europace, vol. 13, no. 7, pp. 1015-1021, 2011.
136. G. Ciuti, P. Valdastri, A. Menciassi, and P. Dario, "Robotic magnetic steering and locomotion of capsule endoscope for diagnostic and surgical endoluminal procedures," Robotica, vol. 28, no. 2, pp. 199-207, 2010.
137. S. Tamaz, R. Gourdeau, A. Chanu, J. Mathieu, and S. Martel, "Real-time MRI-based control of a ferromagnetic core for endovascular navigation," IEEE Trans. Biomed. Eng., vol. 55, no. 7, pp. 1854-1863, 2008. (Pubitemid 351871636)
138. S. Yim and M. Sitti, "Design and analysis of a magnetically actuated and compliant capsule endoscopic robot," in Proc. 2011 IEEE Int. Conf. Robotics and Automation, pp. 4810-4815.
139. X. Wang and M. Q. Meng, "A fast algorithm for field computation in magnetic guidance," in Proc. Int. Conf. Information and Automation, 2008, pp. 1608-1613.
140. O. Ergeneman, G. Dogangil, M. P. Kummer, J. J. Abbott, M. K. Nazeeruddin, and B. J. Nelson, "A magnetically controlled wireless optical oxygen sensor for intraocular measurements," IEEE Sensors J., vol. 8, no. 1, pp. 29-37, 2008.
141. S. Jeon, G. Jang, H. Choi, and S. Park, "Magnetic navigation system with gradient and uniform saddle coils for the wireless manipulation of micro-robots in human blood vessels," IEEE Trans. Magn., vol. 46, no. 6, pp. 1943-1946, 2010.
142. S. Martel, J. B. Mathieu, O. Felfoul, A. Chanu, E. Aboussouan, S. Tamaz, P. Pouponneau, L. H. Yahia, G. Beaudoin, and G. Soulez, "A computer-assisted protocol for endovascular target interventions using a clinical MRI system for controlling untethered microdevices and future nanorobots," Comput. Aided Surg., vol. 13, no. 6, pp. 340-352, 2008.
143. P. Vartholomeos, C. Mavroidis, and N. Hata, "Magnetic targeting of aggregated nanoparticles for advanced lung therapies: A robotics approach," in Proc. 2010 3rd IEEE RAS and EMBS Int. Conf. Biomedical Robotics and Biomechatronics, pp. 861-868.
144. K. B. Yesin, K. Vollmers, and B. J. Nelson, "Analysis and design of wireless magnetically guided microrobots in body fluids," in Proc. IEEE Int. Conf. Robotics and Automation, 2004, vol. 2, pp. 1333-1338.
145. K. B. Yesin, K. Vollmers, and B. J. Nelson, "Modeling and control of untethered biomicrorobots in a fluidic environment using electromagnetic fields," Int. J. Robot. Res., vol. 25, no. 5-6, pp. 527-536, 2006. (Pubitemid 43735587)
146. J. B. Mathieu and S. Martel, "In vivo validation of a propulsion method for untethered medical microrobots using a clinical magnetic resonance imaging system," in Proc. IEEE/RSJ Int. Conf. Intelligent Robots and Systems, San Diego, CA, 2007, pp. 502-508.
147. I. Fleming, M. Balicki, J. Koo, I. Iordachita, B. Mitchell, J. Handa, G. Hager, and R. Taylor, "Cooperative robot assistant for retinal microsurgery," Med. Image Comput. Comput.-Assist. Interv., MICCAI 2008, Berlin/Heidelberg: Springer, vol. 5242, pp. 543-550, 2008.
148. J. Mathieu, G. Beaudoin, and S. Martel, "Method of propulsion of a ferromagnetic core in the cardivascular system through magnetic gradients generated by an MRI system," IEEE Trans. Biomed. Eng., vol. 53, no. 2, pp. 292-299, 2006. (Pubitemid 43168160)
149. S. Martel, J. Mathieu, O. Felfoul, A. Chanu, E. Aboussouan, S. Tamaz, P. Pouponneau, L. Yahia, G. Beaudoin, G. Soulez, and M. Mankiewicz, "Automatic navigation of an untethered device in the artery of a living animal using a conventional clinical magnetic resonance imaging system," Appl. Phys. Lett., vol. 90, no. 11, pp. 114105-1-114105-3, 2007.
150. K. Belharet, D. Folio, and A. Ferreira, "MRI-based microrobotic system for the propulsion and navigation of ferromagnetic microcapsules," Minimal. Invas. Ther. Allied Technol., vol. 19, no. 3, pp. 157-169, 2010.
151. L. Arcese, M. Fruchard, and A. Ferreira, "Nonlinear modeling and robust controller-observer for a magnetic microrobot in a fluidic environment using MRI gradients," in Proc. IEEE/RSJ Int. Conf. Intelligent Robots and Systems, 2009, pp. 534-539.
152. P. Pouponneau, J. C. Leroux, G. Soulez, L. Gaboury, and S. Martel, "Coencapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation," Biomaterials, vol. 32, no. 13, pp. 3481-3486, 2011.
153. S. Martel, O. Felfoul, and M. Mohammadi, "Flagellated bacterial nanorobots for medical interventions in the human body," in Proc. 2nd IEEE RAS and EMBS Int. Conf. Biomedical Robotics and Biomechatronics, 2008, pp. 264-269.
154. A. Luciani, C. Wilhelm, P. Bruneval, P. Cunin, G. Autret, A. Rahmouni, O. Clement, and F. Gazeau, "Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver," Eur. Radiol., vol. 19, no. 5, pp. 1087-1096, 2009.
155. J. Riegler, J. A. Wells, P. G. Kyrtatos, A. N. Price, Q. A. Pankhurst, and M. F. Lythgoe, "Targeted magnetic delivery and tracking of cells using
156. J. Dobson, C. Lewis, and H. Byrne, "Targeted therapy," U.S. Patent 12/293452, 2007.
157. M. Muthana, S. D. Scott, N. Farrow, F. Morrow, C. Murdoch, S. Grubb, N. Brown, J. Dobson, and C. E. Lewis, "A novel magnetic approach to enhance the efficacy of cell-based gene therapies," Gene Ther., vol. 15, no. 12, pp. 902-910, 2008. (Pubitemid 351791477)
158. P. Pouponneau, J. C. Leroux, and S. Martel, "Magnetic nanoparticles encapsulated into biodegradable microparticles steered with an upgraded magnetic resonance imaging system for tumor chemoembolization," Biomaterials, vol. 30, no. 31, pp. 6327-6332, 2009.
159. N. Olamaei, F. Cheriet, G. Beaudoin, and S. Martel, "MRI visualization of a single 15 um navigable imaging agent and future microrobot," in Proc. 2010 Annu. Int. Conf. IEEE Engineering in Medicine and Biology Society (EMBC), pp. 4355-4358.
160. S. Martel, "Microrobotic navigable entities for magnetic resonance targeting," in Proc. 2010 Annu. Int. Conf. IEEE Engineering in Medicine and Biology Society, pp. 1942-1945.
161. M. P. Kummer, J. J. Abbott, B. E. Kratochvil, R. Borer, A. Sengul, and B. J. Nelson, "OctoMag: An electromagnetic system for 5-DOF wireless micromanipulation," IEEE Trans. Robot., vol. 26, pp. 1006-1017, Dec. 2010.
162. L. Arcese, A. Cherry, M. Fruchard, and A. Ferreira, "Dynamic behavior investigation for trajectory control of a microrobot in blood vessels," in Proc. 2010 IEEE/RSJ Int. Conf. Intelligent Robots and Systems, pp. 5774-5779.
163. K. Belharet, D. Folio, and A. Ferreira, "Three-dimensional controlled motion of a microrobot using magnetic gradients," Adv. Robot., vol. 25, no. 8, pp. 1069-1083, 2011.
164. K. Schulze, A. Koch, B. Schopf, A. Petri, B. Steitz, M. Chastellain, M. Hofmann, H. Hofmann, and B. Von Rechenberg, "Intraarticular application of superparamagnetic nanoparticles and their uptake by synovial membrane - An experimental study in sheep," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 419-432, 2005. (Pubitemid 40608961)
165. S. C. Goodwin, C. A. Bittner, C. L. Peterson, and G. Wong, "Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier," Toxicologic. Sci., vol. 60, no. 1, pp. 177-183, 2001. (Pubitemid 32229837)
166. C. Alexiou, R. Jurgons, C. Seliger, S. Kolb, B. Heubeck, and H. Iro, "Distribution of mitoxantrone after magnetic drug targeting: Fluorescence microscopic investigations on VX2 squamous cell carcinoma cells," Int. J. Res. Phys. Chem. Chem. Phys., vol. 220, no. 2, pp. 235-240, 2006. (Pubitemid 43301607)
167. C. Alexiou, W. Arnold, R. J. Klein, F. G. Parak, P. Hulin, C. Bergemann, W. Erhardt, S. Wagenpfeil, and A. S. Lubbe, "Locoregional cancer treatment with magnetic drug targeting," Cancer Res., vol. 60, no. 23, pp. 6641-6648, 2000.
168. C. Alexiou, R. Jurgons, R. Schmid, A. Hilpert, C. Bergemann, F. Parak, and H. Iro, "In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 389-393, 2005. (Pubitemid 40608956)
169. S. K. Pulfer and J. M. Gallo, "Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres," J. Drug Target., vol. 6, no. 3, pp. 215-227, 1998.
170. S. K. Pulfer, S. L. Ciccotto, and J. M. Gallo, "Distribution of small magnetic particles in brain tumor-bearing rats," J. Neuro-Oncol., vol. 41, no. 2, pp. 99-105, 1999.
171. R. Tietze, R. Jurgons, S. Lyer, E. Schreiber, F. Wiekhorst, D. Eberbeck, H. Richter, U. Steinhoff, L. Trahms, and C. Alexiou, "Quantification of drug-loaded magnetic nanoparticles in rabbit liver and tumor after in vivo administration," J. Magn. Magn. Mater., vol. 321, pp. 1465-1468, May 2009.
172. O. Mykhaylyk, A. Cherchenko, A. Ilkin, N. Dudchenko, V. Ruditsa, M. Novoseletz, and Y. Zozulya, "Glial brain tumor targeting of magnetite nanoparticles in rats," J. Magn. Magn. Mater., vol. 225, no. 1-2, pp. 241-247, 2001. (Pubitemid 32335303)
173. Y. Sun, Z. Chen, X. Yang, P. Huang, X. Zhou, and X. Du, "Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy," Nanotechnology, vol. 20, no. 13, pp. 135102-135109, 2009.
174. S. L. Raut, B. Kirthivasan, M. M. Bommana, E. Squillante, and M. Sadoqi, "The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye," Nanotechnology, vol. 21, no. 39, pp. 395102-395111, 2010.
175. B. Chertok, B. A. Moffat, A. E. David, F. Yu, C. Bergemann, B. D. Ross, and V. C. Yang, "Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors," Biomaterials, vol. 29, no. 4, pp. 487-496, 2008. (Pubitemid 350100794)
176. B. Chertok, A. E. David, and V. C. Yang, "Delivery of functional proteins to brain tumor using MRI-monitored, magnetically-targeted nanoparticles," J. Control. Release, vol. 132, no. 3, pp. e61-e62, 2008.
177. H. L. Liu, M. Y. Hua, H. W. Yang, C. Y. Huang, P. C. Chu, J. S. Wu, and I. Tseng, "Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain," Proc. Nat. Acad. Sci., vol. 107, no. 34, pp. 15205-15210, 2010.
178. Z. G. Forbes, B. B. Yellen, K. A. Barbee, and G. Friedman, "An approach to targeted drug delivery based on uniform magnetic fields," IEEE Trans. Magn., vol. 39, no. 5, pp. 3372-3377, 2003.
179. B. B. Yellen, Z. G. Forbes, K. A. Barbee, and G. Friedman, "Model of an approach to targeted drug delivery based on uniform magnetic fields," in Proc. IEEE Int. Magnetics Conf., 2003, pp. EC-06.
180. B. B. Yellen, Z. G. Forbes, D. S. Halverson, G. Fridman, K. A. Barbee, M. Chorny, R. Levy, and G. Friedman, "Targeted drug delivery to magnetic implants for therapeutic applications," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 647-654, 2005. (Pubitemid 40608991)
181. B. Polyak, I. Fishbein, M. Chorny, I. Alferiev, D. Williams, B. Yellen, G. Friedman, and R. J. Levy, "High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents," Proc. Nat. Acad. Sci., vol. 105, no. 2, pp. 698-703, 2008. (Pubitemid 351171771)
182. M. O. Aviles, A. D. Ebner, and J. A. Ritter, "Implant assisted-magnetic drug targeting: Comparison of in vitro experiments with theory," J. Magn. Magn. Mater., vol. 320, no. 21, pp. 2704-2713, 2008.
183. G. H. Iacoba, O. Rotariub, N. J. Strachanband, and U. O. Hafelic, "Magnetizable needles and wires-modeling: An efficient way to target magnetic microspheres in vivo," Biorheology, vol. 41, pp. 599-612, 2004.
184. M. E. Hayden and U. O. Hafeli, " 'Magnetic bandages' for targeted delivery of therapeutic agents," J. Phys.: Condens. Matter, vol. 18, no. 38, pp. S2877-S2891, 2006.
185. U. O. Hafeli, K. Gilmour, A. Zhou, S. Lee, and M. E. Hayden, "Modeling of magnetic bandages for drug targeting: Button vs. Halbach arrays," J. Magn. Magn. Mater., vol. 311, no. 1, pp. 323-329, 2007. (Pubitemid 46401006)
186. A. J. Rosengart, M. D. Kaminski, H. T. Chen, P. L. Caviness, A. D. Ebner, and J. A. Ritter, "Magnetizable implants and functionalized magnetic carriers: A novel approach for noninvasive yet targeted drug delivery," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 633-638, 2005.
187. Z. G. Forbes, B. B. Yellen, D. S. Halverson, G. Fridman, K. A. Barbee, and G. Friedman, "Validation of high gradient magnetic field based drug delivery to magnetizable implants under flow," IEEE Trans. Biomed. Eng., vol. 55, no. 2. pt. 1, pp. 643-649, 2008.
188. P. J. Cregg, K. Murphy, and A. Mardinoglu, "Calculation of nanoparticle capture efficiency in magnetic drug targeting," J. Magn. Magn. Mater., vol. 320, no. 23, pp. 3272-3275, 2008.
189. T. Kubo, T. Sugita, S. Shimose, Y. Nitta, Y. Ikuta, and T. Murakami, "Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.," Int. J. Oncol., vol. 17, no. 2, pp. 309-315, 2000.
190. Z. G. Forbes, B. B. Yellen, K. A. Barbee, and G. Friedman, "Magnetically controllable delivery system for therapeutic agents," U.S. Patent Application 20060041182, Aug. 2005.
191. B. Shapiro, K. Dormer, and I. B. Rutel, "A two-magnet system to push therapeutic nanoparticles," in Proc. American Institute of Physics, Conf. Series, Rostock, Germany, May 2010, vol. 1311, pp. 77-88.
192. A. Komaee, R. Lee, A. Nacev, R. Probst, A. Sarwar, I. Rutel, D. Depireux, K. Dormer, and B. Shapiro, "Putting therapeutic nanoparticles where they need to go by magnet systems design and control," in Magnetic Nanoparticles: From Fabrication to Biomedical and Clinical Applications, N. K. Thanh, Ed. Boca Raton, FL: CRC Press, Apr. 2011.
193. R. Probst, J. Lin, A. Komaee, A. Nacev, Z. Cummins, and B. Shapiro, "Planar steering of a single ferrofluid drop by optimal minimum power dynamic feedback control of four electromagnets at a distance," J. Magn. Magn. Mater., vol. 323, no. 7, pp. 885-896, 2011.
194. R. Ganguly, A. P. Gaind, S. Sen, and I. K. Puri, "Analyzing ferrofluid transport for magnetic drug targeting," J. Magn. Magn. Mater., vol. 289, no. 11, pp. 331-334, 2005. (Pubitemid 40339777)
195. A. Komaee and B. Shapiro, "Magnetic steering of a distributed ferrofluid towards a deep target with minimal spreading," in Proc. 50th IEEE Conf. Decision and Control and European Control Conference, Orlando, FL, Dec. 2011, pp. 7950-7955.
196. R. P. Feynman, R. B. Leighton, and M. Sands, The Feynman Lectures on Physics. Reading, MA: Addison-Wesley, 1964.
197. J. F. Schenck, "The role of magnetic susceptibility in magnetic resonance imaging," Med. Phys., vol. 23, no. 6, pp. 815-850, 1996.
198. A. Vignaud, X. Maitre, G. Guillot, E. Durand, L. de Rochefort, P. Robert, V. Vives, R. Santus, and L. Darrasse, "Magnetic susceptibility matching at the air-tissue interface in rat lung by using a superparamagnetic intravascular contrast agent: Influence on transverse relaxation time of hyperpolarized helium-3," Magn. Reson. Med., vol. 54, no. 1, pp. 28-33, 2005. (Pubitemid 40898393)
199. V. Skumryev, H. J. Blythe, J. Cullen, and J. M. D. Coey, "AC susceptibility of a magnetite crystal," J. Magn. Magn. Mater., vol. 196, no. 1, pp. 515-517, 1999.
200. 3 particles," Chem. Mater., vol. 8, no. 9, pp. 2209-2211, 1996.
201. D. A. Fleisch, A Student's Guide to Maxwell's Equations. Cambridge, U.K.; New York: Cambridge Univ. Press, 2008.
202. G. H. Iacob, O. Rotariu, and H. Chiriac, "A possibility for local targeting of magnetic carriers," J. Optoelectron. Adv. Mater., vol. 6, no. 2, pp. 713-717, 2004. (Pubitemid 38921909)
203. C. S. Lee, H. Lee, and R. M. Westervelt, "Microelectromagnets for the control of magnetic nanoparticles," Appl. Phys. Lett., vol. 79, no. 20, pp. 3308-3310, 2001.
204. C. I. Mikkelsen, "Magnetic separation and hydrodynamic interactions in microfluidic systems," Ph.D. dissertation, Tech. Univ. Denmark, 2005.
205. C. Thirion, W. Wernsdorfer, and D. Mailly, "Switching of magnetization by non-linear resonance studied in single nanoparticles," vol. 2, no. 8, pp. 524-527, 2003.
206. E. P. Furlani and K. C. Ng, "Analytical model of magnetic nanoparticle transport and capture in the microvasculature," Phys. Rev. E, vol. 73, no. 6, pp. 61919-61928, 2006.
207. O. Rotariu and N. J. C. Strachan, "Modeling magnetic carrier particle targeting in the tumor microvasculature for cancer treatment," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 639-646, 2005. (Pubitemid 40608990)
208. M. V. Goycoolea and L. Lundman, "Round window membrane. structure function and permeability: A review," Microsc. Res. Tech., vol. 36, no. 3, pp. 201-211, 1997. (Pubitemid 27120351)
209. E. M. Renkin, "Filtration, diffusion, and molecular sieving through porous cellulose membranes," J. General Physiol., vol. 38, no. 2, pp. 225-243, 1954.
210. J. Weizenecker, B. Gleich, J. Rahmer, H. Dahnke, and J. Borgert, "Three-dimensional real-time in vivo magnetic particle imaging," Phys. Med. Biol., vol. 54, no. 5, pp. L1-L10, 2009.
211. W. F. Ganong, Review of Medical Physiology, 20th ed. New York: Lange, 2001.
212. E. E. Swan, M. J. Mescher, W. F. Sewell, S. L. Tao, and J. T. Borenstein, "Inner ear drug delivery for auditory applications," Adv. Drug Deliv. Rev., vol. 60, no. 15, pp. 1583-1599, 2008.
213. M. D. Seidman, B. G. Shivapuja, and W. S. Quirk, "The protective effects of allopurinol and superoxide dismutase on noise-induced cochlear damage," Otolaryngol. Head Neck Surg., vol. 109, no. 6, pp. 1052-1056, 1993.
214. R. W. Baloh, V. Honrubia, and K. Jacobson, "Benign positional vertigo," Neurology, vol. 37, no. 3, pp. 371-378, 1987.
215. D. McFadden, Tinnitus: Facts, Theories, and Treatments. Washington D.C.: National Academies Press, 1982.
216. J. P. Harris and A. F. Ryan, "Fundamental immune mechanisms of the brain and inner ear," Otolaryngol. Head Neck Surg., vol. 112, no. 6, pp. 639-653, 1995.
217. R. D. Kopke, R. A. Wassel, F. Mondalek, B. Grady, K. Chen, J. Liu, D. Gibson, and K. J. Dormer, "Magnetic nanoparticles: Inner ear targeted molecule delivery and middle ear implant," Audiol. Neurotol., vol. 11, no. 2, pp. 123-133, 2008.
218. F. G. Shellock, Magnetic Resonance Procedures: Health Effects and Safety. New York: Taylor & Francis, 2001.
219. H. Silverstein, J. E. Isaacson, M. J. Olds, P. T. Rowan, and S. Rosenberg, "Dexamethasone inner ear perfusion for the treatment of meniere's disease: A prospective, randomized, double-blind, crossover trial," Otology Neurotol., vol. 19, no. 2, pp. 196-201, 1998. (Pubitemid 28152576)
220. L. J. Hood, Clinical Applications of the Auditory Brainstem Response. San Diego, CA: Singular Pub. Group, 1998.
221. O. Tredan, C. M. Galmarini, K. Patel, and I. F. Tannock, "Drug resistance and the solid tumor microenvironment," J. Nat. Cancer Inst., vol. 99, pp. 1441-1454, Oct. 2007.
222. C. A. Desoer and E. S. Kuh, Basic Circuit Theory, New York: McGraw-Hill, 1969, ch. 1-10.
223. A. Ashkin, "History of optical trapping and manipulation of smallneutral particle, atoms, and molecules," IEEE J. Select. Topics Quantum Electron., vol. 6, no. 6, pp. 841-856, 2000. (Pubitemid 32255302)
224. C. Ropp, R. Probst, Z. Cummins, R. Kumar, A. J. Bergland, S. R. Raghavan, E. Waks, and B. Shapiro, "Manipulating quantum dots to nanometer precision by control of flow," Nano Letters, vol. 10, no. 7, pp. 2525-2530, 2010.
225. S. G. Kim and S. Ogawa, "Insights into new techniques for high resolution functional MRI," Curr. Opin. Neurobiol., vol. 12, no. 5, pp. 607-615, 2002. (Pubitemid 35284099)
226. J. W. Barry, J. J. Bookstein, and J. F. Alksne, "Ferromagnetic embolization. experimental evaluation," Radiology, vol. 138, no. 2, pp. 341-349, 1981.
227. P. Moroz, S. K. Jones, J. Winter, and B. N. Gray, "Targeting liver tumors with hyperthermia: ferromagnetic embolization in a rabbit liver tumor model," J. Surg. Oncol., vol. 78, no. 1, pp. 22-29, 2001.
228. U. Talit, S. Braun, H. Halkin, B. Shargorodsky, and S. Laniado, "Pharmacokinetic differences between peripheral and central drug administration during cardiopulmonary resuscitation," J. Amer. College Cardiol., vol. 6, no. 5, pp. 1073-1077, 1985. (Pubitemid 16219204)
229. S. M. Moghimi, A. C. Hunter, and J. C. Murray, "Long-circulating and target-specific nanoparticles: Theory to practice," Pharmacol. Rev., vol. 53, no. 2, pp. 283-318, 2001.
230. L. J. Nugent and R. K. Jain, "Extravascular diffusion in normal and neoplastic tissues," Cancer Res., vol. 44, no. 1, pp. 238-244, 1984.
231. R. K. Jain, "Determinants of tumor blood flow: A review," Cancer Res., vol. 48, no. 10, pp. 2641-2658, 1988.
232. R. F. Probstein, Physicochemical Hydrodynamics: An Introduction, 2nd ed. New York: Wiley, 1994.
233. M. A. Clauss and R. K. Jain, "Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues," Cancer Res., vol. 50, no. 12, pp. 3487-3492, 1990.
234. R. L. Panton, Incompressible Flow, 2nd ed. New York: Wiley, 1996.
235. F. P. Incropera, Fundamentals of Heat and Mass Transfer. Hoboken, NJ: Wiley, 2007.
236. R. M. Berne and M. N. Levy, Cardiovascular Physiology. St. Louis, MO: Mosby, 1967.
237. K. J. Widder, A. E. Senyei, and D. F. Ranney, "Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents," Adv. Pharmacol. Chemother., New York, NY: Academic Press, vol. 16, pp. 213-271, 1979.
238. A. Lubbe, "Treatment of cancer patients," private communication, 2006.
239. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter, Molecular Biology of the Cell, 5th ed. New York, NY: Garland Science, 2008.
240. Y. Rojanasakul, L. Y. Wang, M. Bhat, D. D. Glover, C. J. Malanga, and J. K. Ma, "The transport barrier of epithelia: A comparative study on membrane permeability and charge selectivity in the rabbit," Pharmaceut. Res., vol. 9, no. 8, pp. 1029-1034, 1992.
241. J. S. Patton and R. M. Platz, "Pulmonary delivery of peptides and proteins for systemic action," Adv. Drug Deliv. Rev., vol. 8, no. 2-3, pp. 179-196, 1992.
242. G. Antoch, F. M. Vogt, L. S. Freudenberg, F. Nazaradeh, S. C. Goehde, J. Barkhausen, G. Dahmen, A. Bockisch, J. F. Debatin, and S. G. Ruehm, "Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology," JAMA, vol. 290, no. 24, pp. 3199-3206, 2003. (Pubitemid 38020681)
243. H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno, "The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer," J. Thorac. Cardiovasc. Surg., vol. 127, no. 4, pp. 1087-1092, 2004. (Pubitemid 38451942)
244. A. L. Schechter, D. F. Stern, L. Vaidyanathan, S. J. Decker, J. A. Drebin, M. I. Greene, and R. A. Weinberg, "The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen," Nature, vol. 312, no. 6, pp. 513-516, 1984. (Pubitemid 15182278)
245. C. C. Badger, C. Anasetti, J. Davis, and I. D. Bernstein, "Treatment of malignancy with unmodified antibody.," Pathol. Immunopathol. Res., vol. 6, no. 5-6, pp. 419-434, 1987.
246. M. A. Olayioye, R. M. Neve, H. A. Lane, and N. E. Hynes, "New EMBO members' review: The ErbB signaling network: Receptor heterodimerization in development and cancer," EMBO J., vol. 19, no. 13, pp. 3159-3167, 2000.
247. J. Baselga, D. Tripathy, J. Mendelsohn, S. Baughman, C. C. Benz, L. Dantis, N. T. Sklarin, A. D. Seidman, C. A. Hudis, and J. Moore, "Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer," J. Clin. Oncol., vol. 14, no. 3, pp. 737-744, 1996.
248. M. A. Cobleigh, C. L. Vogel, D. Tripathy, N. J. Robert, S. Scholl, L. Fehrenbacher, J. M. Wolter, V. Paton, S. Shak, and G. Lieberman, "Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease," J. Clin. Oncol., vol. 17, no. 9, p. 2639, 1999.
249. J. M. Reichert, C. J. Rosensweig, L. B. Faden, and M. C. Dewitz, "Monoclonal antibody successes in the clinic," Nat. Biotechnol., vol. 23, no. 9, pp. 1073-1078, 2005.
250. P. R. Pohlmann, I. A. Mayer, and R. Mernaugh, "Resistance to trastuzumab in breast cancer," Clin. Cancer Res., vol. 15, no. 24, pp. 7479-7491, 2009.
251. R. Nahta and F. J. Esteva, "HER-2-targeted therapy," Clin. Cancer Res., vol. 9, no. 14, pp. 5078-5084, 2003.
252. J. Christiansen and A. K. Rajasekaran, "Biological impediments to monoclonal antibody-based cancer immunotherapy," Mol. Cancer Therapeut., vol. 3, no. 11, pp. 1493-1501, 2004. (Pubitemid 39562594)
253. M. Campoli, R. Ferris, S. Ferrone, and X. Wang, "Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies," Clin. Cancer Res., vol. 16, no. 1, pp. 11-20, 2010.
254. H. Sakahara, T. Saga, H. Onodera, Z. Yao, Y. Nakamoto, M. Zhang, N. Sato, H. Nakada, I. Yamashina, and K. Endo, "Anti murine antibody response to mouse monoclonal antibodies in cancer patients," Cancer Sci., vol. 88, no. 9, pp. 895-899, 1997. (Pubitemid 27475092)
255. M. B. Khazaeli, R. M. Conry, and A. F. LoBuglio, "Human immune response to monoclonal antibodies," J. Immunother., vol. 15, no. 1, pp. 42-52, 1994.
256. P. Carter, L. Presta, C. M. Gorman, J. B. Ridgway, D. Henner, W. L. Wong, A. M. Rowland, C. Kotts, M. E. Carver, and H. M. Shepard, "Humanization of an anti-p185HER2 antibody for human cancer therapy," Proc. Nat. Acad. Sci., vol. 89, no. 10, pp. 4285-4289, 1992.
257. B. M. Fendly, M. Winget, R. M. Hudziak, M. T. Lipari, M. A. Napier, and A. Ullrich, "Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product," Cancer Res., vol. 50, no. 5, pp. 1550-1558, 1990. (Pubitemid 20090470)
258. P. Carter, "Improving the efficacy of antibody-based cancer therapies," Nat. Rev. Cancer, vol. 1, no. 2, pp. 118-129, 2001. (Pubitemid 33741887)
259. M. Little, S. M. Kipriyanov, F. Le Gall, and G. Moldenhauer, "Of mice and men: Hybridoma and recombinant antibodies," Immunol. Today, vol. 21, no. 8, pp. 364-370, 2000. (Pubitemid 30612296)
260. L. A. Khawli, G. K. Miller, and A. L. Epstein, "Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors," Cancer, vol. 73, no. S3, pp. 824-831, 1994.
261. D. M. Goldenberg, S. M. Larson, R. A. Reisfeld, and J. Schlom, "Targeting cancer with radiolabeled antibodies," Immunol. Today, vol. 16, no. 6, pp. 261-264, 1995.
262. A. A. Epenetos, D. Snook, H. Durbin, P. M. Johnson, and J. Taylor-Papadimitriou, "Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms," Cancer Res., vol. 46, no. 6, pp. 3183-3191, 1986. (Pubitemid 16074348)
263. U. S. FDA. (2011). U.S. food and drug administration fundamentals. [Online]. Available: http://www.fda.gov/AboutFDA/Transparency/Basics/ucm192695. htm
264. U. S. FDA, "Design control guidance for medical device manufacturers," Mar. 11, 1997, p. 5.
265. A. F. Chambers, A. C. Groom, and I. C. MacDonald, "Dissemination and growth of cancer cells in metastatic sites," Nat. Rev. Cancer, vol. 2, no. 8, pp. 563-571, 2002.
266. K. Marusina, "Accelerator MS is a powerful new tool," Genet. Eng. Biotechnol. News, vol. 27, Sept. 2007.
267. O. Pagani, E. Senkus, W. Wood, M. Colleoni, T. Cufer, S. Kyriakides, A. Costa, E. P. Winer, and F. Cardoso, "International guidelines for management of metastatic breast cancer: Can metastatic breast cancer be cured?," JNCI J. Nat. Cancer Inst., vol. 102, no. 7, pp. 456-463, 2010.
268. R. K. Jain, "Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy," Science, vol. 307, no. 5706, pp. 58-62, 2005.
269. K. P. Pruessmann, M. Weiger, M. B. Scheidegger, and P. Boesiger, "SENSE: Sensitivity encoding for fast MRI," Magn. Reson. Med., vol. 42, no. 5, pp. 952-962, 1999. (Pubitemid 29521486)
270. M. M. Ter-Pogossian, M. E. Phelps, E. J. Hoffman, and N. A. Mullani, "Positron-emission transaxial tomograph for nuclear imaging (PETT)," Radiology, vol. 114, no. 1, pp. 89-98, 1975.
271. F. Sanchez, J. M. Benlloch, B. Escat, N. Pavon, E. Porras, D. Kadi-Hanifi, J. A. Ruiz, F. J. Mora, and A. Sebastia, "Design and tests of a portable mini gamma camera," Med. Phys., vol. 31, no. 6, pp. 1384-1397, 2004. (Pubitemid 38808507)
272. F. J. Beekman and G. A. de Vree, "Photon-counting versus an integrating CCD-based gamma camera: Important consequences for spatial resolution," Phys. Med. Biol., vol. 50, no. 12, pp. 109-119, 2005.
273. S. Earnshaw, "On the nature of the molecular forces which regulate the constitution of the luminiferous ether," Trans. Cambridge Philos. Soc., vol. 7, no. 1, pp. 97-112, 1842.
274. I. Hilger, R. Hergt, and W. A. Kaiser, "Use of magnetic nanoparticle heating in the treatment of breast cancer," IEE Proc. Nanobiotechnol., vol. 152, no. 1, pp. 33-39, 2005. (Pubitemid 40453794)
275. C. L. Dennis, A. J. Jackson, J. A. Borchers, P. J. Hoopes, R. Strawbridge, A. R. Foreman, J. Van Lierop, C. Gruttner, and R. Ivkov, "Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia," Nanotechnology, vol. 20, no. 35, p. 395103, 2009.
276. E. S. Handy, R. Ivkov, D. Ellis-Busby, and A. Foreman, "Thermotherapy via targeted delivery of nanoscale magnetic particles," No. 10/176,950, 2006.
277. P. M. Pardalos, "Global optimization algorithms for linearly constrained indefinite quadratic problems," Comput. Math. Applicat., vol. 21, no. 6-7, pp. 87-97, 1991.
278. R. Horst and P. M. Pardalos, Handbook of Global Optimization, vol. 1. Norwell, MA: Kluwer, 1995.
279. D. Price, I. Delakis, C. Renaud, and R. Dickinson. (2008). MRI scanners: A buyer's guide [Online]. The Buyer's Guide to Respiratory Care Products. Available: http://www.ersbuyersguide.org/
280. W. R. Adey, "Biological effects of electromagnetic fields," J. Cell. Biochem., vol. 51, no. 4, pp. 410-410, 1993.
281. G. A. Mesyats, Pulsed Power. New York: Springer Science+ Business Media, 2005.
282. S. K. Imam, "Molecular nuclear imaging: The radiopharmaceuticals (review)," Cancer Biother. Radiopharmaceut., vol. 20, no. 2, pp. 163-172, 2005.
283. E. C. Frey, Z. W. Ju, and B. M. W. Tsui, "A fast projector-backprojector pair modeling the asymmetric, spatially varying scatter response function for scatter compensation in SPECT imaging," IEEE Trans. Nuclear Sci., vol. 40, no. 4, pp. 1192-1197, 1993.
284. S. Staelens, T. de Wit, and F. Beekman, "Fast hybrid SPECT simulation including efficient septal penetration modelling (SP-PSF)," Phys. Med. Biol., vol. 52, no. 11, pp. 3027-3043, 2007. (Pubitemid 46795245)
285. H. Zaidi, "Scatter modelling and correction strategies in fully 3-D PET," Nuclear Med. Commun., vol. 22, no. 11, pp. 1181-1184, 2001. (Pubitemid 33030169)
286. I. R. Young, A. S. Hall, C. A. Pallis, G. M. Bydder, N. J. Legg, and R. E. Steiner, "Nuclear magnetic resonance imaging of the brain in multiple sclerosis," Lancet, vol. 318, no. 8255, pp. 1063-1066, 1981.
287. B. H. Hasegawa, "The physics of medical X-ray imaging," Madison, WI: Medical Physics Pub. Co., 1990.
288. S. Webb, The Physics of Medical Imaging. New York: Taylor & Francis, 1988.
289. M. A. Hahn, A. K. Singh, P. Sharma, S. C. Brown, and B. M. Moudgil, "Nanoparticles as contrast agents for in-vivo bioimaging: Current status and future perspectives," Anal. Bioanal. Chem., vol. 399, no. 1, pp. 1-25, 2010.
290. O. Brunke, S. Odenbach, R. Jurgons, C. Alexiou, I. Hilger, and F. Beckmann, "Determination of the magnetic particle distribution in tumour tissue by means of X-ray tomography," J. Phys. Condens. Matter, vol. 18, no. 38, pp. S2903-S2917, 2006. (Pubitemid 44523009)
291. D. L. Bailey, Positron Emission Tomography: Basic Sciences. Berlin: Springer-Verlag, 2005.
292. E. L. Bradley, J. Cella, S. Majewski, V. Popov, J. Qian, M. S. Saha, M. F. Smith, A. G. Weisenberger, and R. E. Welsh, "A compact gamma camera for biological imaging," IEEE Trans. Nuclear Sci., vol. 53, no. 1, pp. 59-65, 2006.
293. J. A. Sorenson, M. E. Phelps, and S. R. Cherry, Physics in Nuclear Medicine. Orlando, FL: Grune & Stratton, 1987.
294. A. S. Arbab, K. Koizumi, K. Toyama, and T. Araki, "Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines," J. Nuclear Med., vol. 37, no. 9, pp. 1551-1556, 1996. (Pubitemid 26321646)
295. B. Caner, M. Kitapcl, M. Unlu, G. Erbengi, T. Calikolu, T. Gou, and C. Bekdik, "Technetium-99m-MIBI uptake in benign and malignant bone lesions: A comparative study with technetium-99m-MDP," J. Nuclear Med., vol. 33, no. 3, pp. 319-324, 1992.
296. M. Rodrigues, F. Chehne, W. Kalinowska, C. Zielinski, and H. Sinzinger, "Comparative 99m Tc-MIBI, 99m tc-tetrofosmin and 99m tc-furifosmin uptake in human soft tissue sarcoma cell lines," Eur. J. Nuclear Med. Mol. Imag., vol. 27, no. 12, pp. 1839-1843, 2000.
297. T. F. Massoud and S. S. Gambhir, "Molecular imaging in living subjects: Seeing fundamental biological processes in a new light," Genes Dev., vol. 17, no. 5, pp. 545-580, 2003.
298. P. Debbage and W. Jaschke, "Molecular imaging with nanoparticles: Giant roles for dwarf actors," Histochem. Cell Biol., vol. 130, no. 5, pp. 845-875, 2008.
299. P. H. Jarritt and P. D. Acton, "PET imaging using gamma camera systems: A review," Nuclear Med. Commun., vol. 17, no. 9, pp. 758-766, 1996.
300. T. K. Lewellen, R. S. Miyaoka, and W. L. Swan, "PET imaging using dual-headed gamma cameras: An update," Nuclear Med. Commun., vol. 20, no. 1, pp. 5-12, 1999.
301. J. T. Kuikka, A. Sohlberg, and M. Husso-Saastamoinen, "PET imaging using a triple-head gamma camera," Clin. Physiol. Funct. Imag., vol. 22, no. 5, pp. 328-331, 2002.
302. A. Leschhorn, J. P. Embs, and M. Lucke, "Magnetization of rotating ferrofluids: The effect of polydispersity," J. Phys.: Condens. Matter, vol. 18, no. 38, pp. S2633-S2642, 2006. (Pubitemid 44522991)
303. R. Muller, R. Hergt, S. Dutz, M. Zeisberger, and W. Gawalek, "Nanocrystalline iron oxide and Ba ferrite particles in the superparamagnetismferromagnetism transition range with ferrofluid applications," J. Phys.: Condens. Matter, vol. 18, no. 38, pp. S2527-S2542, 2006. (Pubitemid 44522985)
304. T. Neuberger, B. Schopf, H. Hofmann, M. Hofmann, and B. von Rechenberg, "Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system," J. Magn. Magn. Mater., vol. 293, no. 1, pp. 483-496, 2005. (Pubitemid 40608969)
305. F. K. Wacker, K. Reither, W. Ebert, M. Wendt, J. S. Lewin, and K. J. Wolf, "MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH u 555 c as an intravascular contrast agent: Study in pigs," Radiology, vol. 226, no. 2, pp. 459-464, 2003. (Pubitemid 36313435)
306. H. Benveniste and S. Blackband, "MR microscopy and high resolution small animal MRI: Applications in neuroscience research," Progr. Neurobiol., vol. 67, pp. 393-420, Aug. 2002. (Pubitemid 35257912)